Sectivia

Johnson & JohnsonJNJ

NYSE · USA · Segment 2 of 8 in the Medicine, pharma & life science value chain: Big pharma

American healthcare group with a large pharmaceutical division (Innovative Medicine) and medtech division (MedTech).

Big pharma: Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas.

Key metrics

Market cap
$626B
Price
$256.79
Today
−0.9%
Return YTD
+25.2%
Return 1Y
+65.8%
P/E
29.7
P/S
6.5
P/B
7.7

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

Big pharmaMedtech exposureOncologyMedtech

In the value chain

Products & services

  • Medicine (immunology/oncology)
  • Medical devices
  • Surgery

Competitors

Risks

  • Litigation (talc)
  • Patent cliff (Stelara)

Same segment: Big pharma

See where Johnson & Johnson sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →